跳至主要内容
临床试验/NCT07219719
NCT07219719招募中1 期

Temporal Interference for Thalamocortical Activity and Network Modulation

University of Wisconsin, Madison2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年12月1日最近更新:
干预措施

试验速览

阶段
1 期
状态
招募中
入组人数
40
试验地点
2
主要终点
Change in thalamocortical functional connectivity (FC): resting state fMRI

研究概览

简要总结

The goal of this clinical trial is to find out whether a type of electrical brain stimulation, called temporal interference stimulation, can temporarily change the way different parts of the brain communicate with each other.

Participants will:

  • Complete two stimulation phases - overnight and during wakefulness
  • Undergo two MRIs per study phase

详细描述

This study will evaluate the effectiveness of personalized thalamic temporal interference transcranial electrical stimulation (TI-TES) to modulate thalamocortical activity and connectivity in healthy adults. Using a within-subject, counterbalanced crossover design, participants will complete two stimulation phases: (1) repeated overnight TI-TES or sham stimulation during NREM sleep and (2) repeated during quiet wakefulness. Each phase consists of two sessions. Phases are separated by a ≥4-week washout. Resting-state functional magnetic resonance imaging (fMRI) will be acquired before and after each phase to assess sustained changes in thalamocortical functional connectivity, with high-density EEG providing secondary measures of brain-state-specific oscillatory modulation (sigma/spindles in sleep, alpha in wake).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Adults aged 18-50
  • Medically healthy
  • U.S. citizen or holding permanent resident status
  • English-speaking

排除标准

  • Any current or past history of neurological disorders or acquired neurological disease (e.g. stroke, traumatic brain injury), including intracranial lesions (including clinically significant findings identified in first MRI)
  • History of inpatient psychiatric hospitalization
  • History of head trauma resulting in prolonged loss of consciousness; or a history of greater than 3 grade I concussions
  • Current history of poorly controlled headaches including intractable or poorly controlled migraines
  • Any systemic illness or unstable medical condition that may cause a medical emergency in case of a provoked seizure (cardiac malformation, cardiac dysrhythmia, asthma, etc.)
  • History of seizures, diagnosis of epilepsy, history of abnormal (epileptiform) EEG, or family history of treatment resistant epilepsy except for a single seizure of benign etiology (e.g. febrile seizures) in the judgment of a board-certified neurologist
  • Possible pregnancy or plan to become pregnant in the next 6 months (self reported)
  • Any metal in the head
  • Any medical devices or implants (i.e. cardiac pacemaker, medication infusion pump, cochlear implant, vagal nerve stimulator)
  • Dental implants
  • Permanent retainers
  • Any hair braid, dreadlocks, hair pieces, or extensions which cannot be taken out before the study sessions
  • Any head coverings or headdress that participant feels uncomfortable removing for the purposes of study sessions
  • Any medication that may alter seizure threshold taken during the study i.e., Attention-deficit/hyperactivity disorder (ADHD) stimulants (Adderall, amphetamine); Tricyclic/atypical antidepressants (amitriptyline, doxepin, imipramine, maprotiline, nortriptyline, bupropion); SSRIs (Escitalopram, Fluoxetine, Sertraline); Antipsychotics (chlorpromazine, clozapine), Bronchodilators (theophylline, aminophylline); Antibiotics (fluoroquinolones, imipenem, penicillin, cephalosporins, metronidazole, isoniazid); Antivirals (valacyclovir, ritonavir); over the counter antihistamines (diphenhydramine, Benadryl); Estradiol-based birth control
  • Claustrophobia (a fear of small or closed places)
  • Back problems that would prevent lying flat for up to two hours
  • Regular night-shift work (second or third shift)
  • Sleep apnea or other sleep disorder (self-reported)

研究组 & 干预措施

Stimulation

Experimental

Participants will complete two stimulation phases-overnight TI-TES during non-rapid eye movement (NREM) sleep and TI-TES during quiet wakefulness

干预措施: Temporal Interference Transcranial electrical stimulation (TI-TES) (Device)

Sham stimulation

Sham Comparator

~10 participants will be assigned to sham stimulation

干预措施: Sham stimulation (Device)

结局指标

主要结局

Change in thalamocortical functional connectivity (FC): resting state fMRI

时间窗: Pre- to post-intervention, up to 2 weeks

Resting-state fMRI will be used to assess changes in thalamocortical functional connectivity before and after repeated thalamic TI-TES delivered during NREM sleep and quiet wakefulness.

Difference in magnitude of FC changes between sleep and wake

时间窗: 8 weeks

The magnitude of FC changes between sleep and wake stimulation phases will be evaluated.

Difference in spatial distribution of FC changes between sleep and wake

时间窗: 8 weeks

The spatial distribution of FC changes between sleep and wake stimulation phases will be evaluated.

次要结局

  • Change in sigma-band power (EEG, sleep phase)(During and after each overnight stimulation session, up to 1 week)
  • Change in alpha band power during wake stimulation sessions(During and after each wake stimulation session, up to 1 week)
  • Return to baseline thalamocortical FC(8 weeks)
  • Change in structural thalamocortical connectivity(Pre- to post-intervention, up to 2 weeks)
  • Change in mood(Baseline to 12 weeks)
  • Change in Boston Cognitive Assessment (BoCA)(Baseline to 12 weeks)
  • Change in spindle characteristics: Density(Up to 1 week)
  • Change in spindle characteristics: Amplitude(Up to 1 week)
  • Change in spindle characteristics: Duration(Up to 1 week)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验